BiomX Inc. 2026年季度报告

BIOMX, INC.Form 10-QMarch 31, 2026 PART I — FINANCIAL INFORMATIONItem 1 – Unaudited Condensed Consolidated Financial StatementsCondensed Consolidated Balance Sheets – March 31,2026 (unaudited) and December 31, 2025F-1Condensed Consolidated Statements of Operations for the three months ended March 31, 2026 and 2025 (unaudited)F-2Condensed Consolidated Statement of Changes in Stockholders’ Equity (deficit) for the three months ended March 31,2026 and 2025 (unaudited)F-3Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2026 and 2025(unaudited)F-4Notes to Unaudited Condensed Consolidated Financial StatementsF-5-F-21Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations2Item 3 – Quantitative and Qualitative Disclosures About Market Risk11Item 4 – Controls and Procedures11PART II — OTHER INFORMATION12Item 1 – Legal Proceedings12Item 1A – Risk Factors12Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds12Item 3 – Defaults upon Senior Securities12Item 4 – Mine Safety Disclosures12Item 5 – Other Information12Item 6 – Exhibits12Exhibit IndexSIGNATURES13i CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION This Quarterly Report on Form 10-Q (the “Quarterly Report”) includes “forward-looking statements” within the meaning ofthe Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”),and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The statements contained herein that arenot purely historical are forward-looking statements. Forward-looking statements include statements about our expectations, beliefs,plans, objectives, intentions, assumptions and other statements that are not historical facts. Words or phrases such as “anticipate,”“believe,” “continue,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “will” or similarwords or phrases, or the negatives of those words or phrases, may identify forward-looking statements, but the absence of these wordsdoes not necessarily mean that a statement is not forward-looking. For example, we are making forward-looking statements when wediscuss our business strategy and plans, including our strategic transition to defense, security, and critical infrastructure technology ●our ability to maintain compliance with the continued listing standards of the NYSE American, including in connectionwith the deficiency notice we received from NYSE Regulation on March 25, 2026 with respect to Sections 1003(a)(i),1003(a)(ii) and 1003(a)(iii) of the NYSE American Company Guide, the Compliance Plan we submitted to NYSERegulation on April 24, 2026;●substantial doubt about our ability to continue as a going concern; ●compliance with Israeli defense export control laws, U.S. defense export control laws (including the International Trafficin Arms Regulations and the Export Administration Regulations), and other applicable defense, security and counter-proliferation laws and regulations;●expenses associated with compliance with ongoing regulatory obligations and successful continuing regulatory review;●political, economic and military instability in the State of Israel and the surrounding region, including the ongoing armedconflicts with Hamas, Hezbollah and Iran-affiliated organizations, and the potential for escalation; For a detailed discussion of these and other risks, uncertainties and factors, see Part I, Item 1A “Risk Factors” of our AnnualReport on Form 10-K for the year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission (the “SEC”) onFebruary 19, 2026 (the “2025 10-K”), and the updated risk factors set forth in our Current Report on Form 8-K filed with the SEC onMay 5, 2026 (the “May 5 8-K”). All forward-looking statements contained in this Quarterly Report speak only as of the date hereof.Except as required by law, we are under no duty to (and expressly disclaim any such obligation to) update or revise any of the forward- BIOMX INC. AS OF MARCH 31, 2026USD IN THOUSANDS Condensed Consolidated Interim Balance Sheets (unaudited)F-1Condensed Consolidated Interim Statements of Comprehensive Loss (unaudited)F-2Condensed Consolidated Interim Statements of Capital Deficiency (unaudited)F-3Condensed Consolidated Interim Statements of Cash Flows (unaudited)F-4Notes to Condensed Consolidated Interim Financial StatementsF-5-F-21 BIOMX INC.UNAUDITED CONDENSED CONSOLIDATED INTERIM STATEMENTS OF COMPREHENSIVE LOSS(U.S, dollars in thousands except share and per share data) Operating expenses: BIOMX INC.NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (unaudited)(U.S, dollars in thousands except share and per share data) NOTE 1 – GENERAL A.Organization and Nature of Operations BiomX Inc. (individually and together with its subsidiaries, as applicable, the “Company” or “BiomX”) was incorporatedin Delaware on